Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis
Clinical trial NCT00309062 · COMPLETED
Trial details
- NCT number
- NCT00309062
- Sponsor
- Allergopharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2006-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.